What is AOD-9604 & MOTS-c Peptide Therapy?
AOD-9604 and MOTS-c peptide therapy involves the use of two bioactive peptides that influence how the body regulates fat metabolism and cellular energy. These compounds interact with biological pathways related to fat breakdown, mitochondrial function, and metabolic signaling.
In a clinical setting, a physician evaluates whether these peptides are appropriate for patients experiencing metabolic concerns such as impaired fat loss, reduced energy, or decreased metabolic efficiency. Appropriate treatment options depend on how your body is currently functioning, not just your goals.
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone that targets fat metabolism without significantly affecting blood sugar or growth pathways. It works by signaling the body to increase lipolysis, which is the breakdown of stored fat, while also helping reduce the formation of new fat cells.
Patients typically explore AOD-9604 when working toward fat loss or body composition changes, especially when traditional approaches have stalled. It is commonly administered through subcutaneous injection under medical guidance to ensure proper dosing and response monitoring.
What is MOTS-c?
MOTS-c is a peptide produced within the mitochondria that helps regulate how cells use energy. It plays a role in improving insulin sensitivity, supporting glucose utilization, and enhancing metabolic efficiency at the cellular level.
Patients often consider MOTS-c when dealing with low energy, reduced metabolic flexibility, or difficulty maintaining body composition. It is typically administered via injection and used within a structured plan that accounts for lifestyle, nutrition, and overall metabolic health.
What is Peptide Therapy?
Peptide therapy uses targeted signaling molecules to influence specific biological processes in the body. Unlike general supplements, peptides bind to receptors and trigger defined responses, such as increased fat metabolism or improved cellular energy production. Peptide therapy is typically administered as subcutaneous injections on a prescribed schedule, based on your treatment plan and response.
A physician-guided approach ensures the therapy aligns with your physiology, current health status, and goals. This process helps determine whether peptides are appropriate, how they should be used, and how they fit into a larger treatment plan.
How Peptide Therapy is Used for Metabolic Support
AOD-9604 and MOTS-c are used to support different aspects of metabolism. AOD-9604 focuses on fat breakdown and limiting fat storage, while MOTS-c improves how efficiently cells produce and use energy.
When combined in a care plan, they may support body composition changes, improved energy levels, and better metabolic function. A clinician determines how to use them based on your current metabolic state, rather than applying a fixed protocol. Remember that getting a proper medical evaluation from a licensed physician is crucial before relying on peptide-related claims found online.
Peptides for Metabolic Wellness Support
These peptides target core metabolic pathways that influence how your body processes nutrients and stores energy. AOD-9604 promotes fat utilization, while MOTS-c supports cellular energy regulation.
This approach may benefit patients who want to improve metabolic efficiency rather than relying only on calorie restriction or exercise changes.
Peptides for Energy and Recovery Goals
MOTS-c directly affects mitochondrial function, which drives energy production at the cellular level. Improved mitochondrial efficiency can support more stable energy levels and better recovery from physical or metabolic stress.
AOD-9604 may also contribute indirectly by improving body composition, which can influence overall energy balance.
Peptides for Body Composition Support
AOD-9604 targets fat metabolism, making it relevant for patients focused on reducing body fat while maintaining lean mass. MOTS-c complements this by improving how the body uses glucose and energy.
Together, they may support more efficient changes in body composition when used alongside a structured plan.
Clinical Context & Research Overview
Important: Peptide therapy for metabolic support should be discussed with a licensed clinician. Research around AOD-9604 and MOTS-c includes experimental, investigational, and limited human-interest discussion, but evidence quality, clinical standards, and regulatory context can vary.
This page is educational. It does not guarantee outcomes, and it should not be interpreted as a promise that a specific peptide will improve metabolism, body composition, weight-related goals, or energy levels in every patient.
Patients should speak with their treating clinician about the current evidence, regulatory status, possible alternatives, and whether a treatment plan is appropriate for their medical history and goals.
What Current Research Suggests
Research on AOD-9604 shows activity in pathways related to fat breakdown and reduced fat storage. Studies on MOTS-c highlight its role in mitochondrial signaling, insulin sensitivity, and metabolic regulation.
Most findings come from early-stage or limited human studies, which provide insight into mechanisms but do not establish consistent clinical outcomes across populations.
Limitations of Available Evidence
Research varies based on study design, dosing, and delivery method. Many studies examine isolated mechanisms rather than long-term patient outcomes.
Real-world results depend on factors such as adherence, overall health, and how these peptides are integrated into a broader treatment plan.
Why Medical Supervision is Required
Peptides affect metabolic and cellular processes that vary from person to person. A clinician evaluates your baseline health, identifies potential risks, and determines appropriate dosing and monitoring.
This oversight helps ensure the treatment aligns with your physiology and reduces the likelihood of ineffective or inappropriate use.
How Telehealth Peptide Therapy Works
Availability varies by state and clinician licensure
Online Consultation Process
You begin with a telehealth consultation where a clinician reviews your symptoms, history, and goals. This step determines whether peptide therapy fits your situation.
Prescription and Treatment Planning
If appropriate, the clinician designs a plan that includes dosing, administration method, and how the peptides integrate with your overall care strategy.
Ongoing Monitoring
Follow-up care tracks your response, adjusts treatment if needed, and ensures safety throughout the process.
Complete Our Online Intake Form
Fill out our short online intake form. Our doctor will review your information and determine if you're a good candidate for AOD-9604 & MOTS-c peptide therapy.
Meet with Our Doctor
Meet with our doctor to discuss the benefits of peptide therapy injections, how they work, potential side effects, and what to expect during treatment.
Receive Your Medication at Home
After you submit payment to the pharmacy, your AOD-9604 & MOTS-c therapy will be conveniently delivered to your home. You’ll receive detailed instructions on how to use it safely and effectively, along with ongoing support from our team to help you achieve the best results.
A telehealth consultation is intended to determine whether peptide therapy should be considered, whether other treatment paths may be more appropriate, and what safety or monitoring considerations should be reviewed before moving forward.
Meet Our Doctor
The Sanctuary Wellness Institute works with medical wellness physicians who provide telehealth consultations with a trust-focused, educational approach. Patients can review clinician credentials, medical oversight, and care philosophy before booking.
Dr. Kalpana Sundar, DO
Learn MoreSafety & Treatment Considerations
Peptide therapy should always be discussed within a physician-led context. While some patients tolerate treatment well when appropriately evaluated, safety depends on individual health status, medications, and clinical judgment.
- Individual Safety Profile: Suitability depends on diagnosis, medical history, current medications, and clinician evaluation.
- Potential Reactions: Some patients may experience mild or temporary effects such as injection site irritation, fatigue, nausea, headaches, or other unexpected symptoms.
- Administration Considerations: Treatment approach, dosing, and frequency should be guided by a licensed clinician and dispensing pharmacy.
- Medication & Condition Review: Peptide therapy may not be appropriate for patients with certain medical conditions or those taking specific medications.
- Monitoring & Follow-Up: Ongoing evaluation, symptom tracking, or additional testing may be recommended depending on the patient and treatment plan.
- Evidence & Research Limitations: Research surrounding peptides like AOD-9604 and MOTS-c varies in quality and scope, and clinical standards continue to evolve.
This content is for educational purposes only and does not replace professional medical advice. Patients should consult a licensed healthcare provider to determine appropriate care.
Frequently Asked Questions
AOD-9604 and MOTS-c are most commonly administered as subcutaneous injections. This method allows for consistent absorption and is the standard approach used in clinician-guided treatment plans. Your doctor and dispensing pharmacy should provide detailed instructions on how to administer the medication you are prescribed, along with guidance on dosing, frequency, and safe handling.
Some patients may come across other formats such as oral capsules, nasal sprays, or topical products online. Be aware that these alternatives vary in absorption and reliability, and many have limited evidence supporting consistent systemic effects.
Response time varies. A consultation can help set realistic expectations based on your symptoms, health history, and the overall treatment strategy being considered.
Safety depends on the patient, the treatment plan, and careful medical review. Patients should discuss risks, contraindications, and alternatives with a licensed clinician.
Yes. If treatment is recommended, a clinician evaluation and valid prescription are required.
AOD-9604 and MOTS-c are currently not approved by the FDA as drugs for treating specific medical conditions, though they are commonly used for improving metabolic efficiency. In February 2026, the U.S. Secretary of Health and Human Services announced that several peptides may be removed from the FDA’s Category 2 compounding restriction list. If finalized by the FDA, this would allow licensed pharmacies to compound them again under a physician’s prescription.
AOD-9604 is not currently on the FDA’s compounding restriction list, but MOTS-c is. Their use should involve appropriate professional guidance, even though some products containing these peptides are available over the counter.
Remember to be cautious when researching peptides online; information about their effectiveness and how to obtain them is often incomplete, misleading, or taken out of context. It’s important to consult a licensed physician who can evaluate your individual needs, explain the potential risks and benefits, and guide you in obtaining peptides safely through a reputable, licensed pharmacy.
Some patients may not be appropriate candidates based on active conditions, medication use, or other medical factors. Proper screening is important.
Some patients may need additional evaluation or labs depending on symptoms, history, and the clinician's judgment.
Related Resources
Explore more about The Sanctuary Wellness Institute and how to get a consultation with one of our qualified physicians:
- Visit The Sanctuary Wellness Institute homepage
- Review Dr. Kalpana Sundar's profile
- Contact the practice to discuss next steps
- Margret I. Moréa; David Kenley. Journal of Endocrinology and Metabolism. “Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health.” 2014.
- Yuejun Zheng, et al. Frontiers in Endocrinology. “MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.” 2023.
- The New York Times, Christina Jewett. “FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes.” March 2026.
- FDA.Gov. “Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks.”
Let's Talk
Our mission is to provide easily accessible health and wellness services to help our patients live their best lives. Reach out to us to learn more about our services.